EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. (IST:ECILC)

Market Cap	59.89B +96.7%
Revenue (ttm)	9.87B -14.0%
Net Income	2.09B +55.9%
EPS	3.05 +55.9%
Shares Out	685.26M
PE Ratio	28.67
Forward PE	n/a
Dividend	1.75 (2.00%)
Ex-Dividend Date	May 6, 2026

Volume	25,629,476
Average Volume	9,501,910
Open	88.00
Previous Close	87.40
Day's Range	87.70 - 93.30
52-Week Range	40.40 - 132.60
Beta	0.25
RSI	36.35
Earnings Date	Apr 30, 2026

About IST:ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses in Turkey and internationally. The Health segment is involved in the production, marketing, and sale of medicines related to human health and veterinary medicines. The Real Estate Development segment engages in development of real estate properties; rental activities for serum facilities; and providing consulting services on land development and project management. The company was incorpo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1951
• Employees: 1,071
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ECILC

Financial Performance

In 2025, IST:ECILC's revenue was 9.87 billion, a decrease of -13.98% compared to the previous year's 11.48 billion. Earnings were 2.09 billion, an increase of 55.90%.